knowledge -WSS

knowledge

author：hotspot 2025-10-01 00:59:17 - browse：4747

Two people in protective equipment work in a lab. — JUAN MABROMATA/AFP via Getty Images

Biosimilars are no longer a new and untested class of medicines. Today, they provide critical treatment options across multiple therapeutic areas. Since the Biologics Price Competition and Innovation Act of 2009 created a regulatory pathway for biosimilar medicine review in the U.S., 37 biosimilars have come to market offering the potential to increase patient choice and cost savings. And according to the 2023 analysis from IQVIA, biosimilars are expected to generate $181 billion in savings for the U.S. health care system over the next five years.

This progress is due, in part, to thoughtfully considered, scientifically robust regulatory standards, which have instilled confidence among health care providers and patients while protecting safety. As a former associate director of therapeutic biologics at the Food and Drug Administration, I had the privilege of helping create and lead implementation of the regulatory framework for biosimilars. The FDA took great care to apply appropriate scientific rigor to the development and approval standards. While I have since moved to Amgen, my goals have remained focused on biosimilar product quality and efficacy, patient safety, and prescriber confidence.

More than a decade later, collective efforts by biosimilar manufacturers and the FDA are paying off.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Guidelines to prevent youth baseball injuries need more muscle
Next article： FDA approves first blood sugar monitor without finger pricks

WSS

New requirements coming in 2024 for Americans traveling to Europe

Medical student insurance fails on mental health care coverage

FDA approves first blood sugar monitor without finger pricks

Senate HELP committee spars over health care workforce policies

Senate HELP committee spars over health care workforce policies

Hundreds of thousands march in Israel. Former security chiefs beg Netanyahu to halt legal overhaul

Wikipedia

knowledge

leisure time

Alkermes shareholders re

Transgender women dream of pregnancy via uterus transplants

How one medical school became remarkably diverse

Readout LOUD podcast: possible new ALS drug, artificial wombs

Trump demands the U.S. pay no more for drugs than other countries … again

Biotech lab space demand falls sharply

The high cost of giving birth even with insurance

Charges dismissed against white woman who spat on Black woman during protests in Connecticut

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Drone hits Crimean ammunition depot as strikes kill, wound civilians and journalists in Ukraine

hotspot

'The Earth is screaming at us': Gov. Inslee calls for climate action amid record heat

Hundreds of thousands march in Israel. Former security chiefs beg Netanyahu to halt legal overhaul

CommonSpirit Health keeps growing, even as it loses money

How AI helped researchers track recovery from depression

Senate HELP committee spars over health care workforce policies

New requirements coming in 2024 for Americans traveling to Europe

entertainment

leisure time

explore

hotspot